Paul Watts,
Distinguished Professor and Research Chair,
Nelson Mandela University
Prof Paul Watts started his career as a lecturer at the University of Hull in 2002, being promoted to full professor in 2011. At the University of Hull he led the micro reactor and flow technology group. In February 2013, he moved to Nelson Mandela University to hold the Distinguished Professorship and Research Chair in Microfluidic Bio/Chemical Processing. He has published of over 120 highly cited papers. He strongly believes that scientists should conduct research that impacts society; the biggest project underway involves the local production of key drugs as the morbidity and mortality from major diseases are much more devastating in Africa than in other regions of the world. The vision is that new technology will be used within South Africa to manufacture generic drugs; this could create jobs and a new manufacturing industry within the country.
Welcome and Introduction by Conference Chairperson and Vision of Continuous Flow - Local API Manufacturing
Monday, 25 March 2024 at 09:00
Add to Calendar ▼2024-03-25 09:00:002024-03-25 10:00:00Europe/LondonWelcome and Introduction by Conference Chairperson and Vision of Continuous Flow - Local API ManufacturingFlow Chemistry European Summit 2024 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Africa has a variety of formulation companies, however the active pharmaceutical ingredients are generally imported. This results in increased drug costs, making medications unaffordable to many patients in Africa.
When micro reactor technology and flow chemistry was introduced it was seen as a research and development tool, however it is now being used to produce large quantities of product. The drivers being increased safety, higher yields and purity as well as reduced production cost. There is now a range of commercial reactors on the market, which means that most companies are investigating this technology to rapidly screen reactions, leading to the identification of reaction conditions that are suitable for use at a production level.
COVID-19 caused drug shortages around the world, demonstrating the need for local production capacity. To this effect, we are working on developing local drug manufacturing capacity in Africa using continuous flow technology, with the goal of lowering the cost of drugs, improving drug accessibility and ultimately improving Africa’s health. A selection of cases studies will be presented.
Add to Calendar ▼2024-03-25 00:00:002024-03-26 00:00:00Europe/LondonFlow Chemistry European Summit 2024Flow Chemistry European Summit 2024 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2024-03-25 09:00:002024-03-25 10:00:00Europe/LondonWelcome and Introduction by Conference Chairperson and Vision of Continuous Flow - Local API ManufacturingFlow Chemistry European Summit 2024 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
